Nutritional Management in Type 1 Diabetes Mellitus by Marković- Jovanović, Snežana
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 19
Nutritional Management in Type 1 Diabetes Mellitus
Snežana Marković- Jovanović
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/52465
1. Introduction
An optimal nutrition along with insulin therapy in pations with type 1 diabetes, is the pre‐
requisite for normal growth and development, adequate pubertal development, and regular
performance in school and extracurricular activities, including sports in diabetic patients.
Moreover, a balanced and healthy diet prevents hyper- or hypoglycemia and delays devel‐
opment of microvascular diabetic complications, including diabetic nephropathy. (Kliegman
M Robert et al., 2007)
Dietary recommendations for children with diabetes are based on healthy eating recommen‐
dations suitable for all children and adults and therefore the whole family. Nutritional ad‐
vice must be adapted to cultural, ethnic and family traditions and the psychosocial needs of
the individual child. Likewise the choice of insulin regimen should take into account the di‐
etary habits and lifestyle of the child.(NICE, 2004., American Diabetes Association, 2003)
A meal plan based on the individual’s usual food intake should be determined and insulin
therapy integrated into the usual eating and exercise patterns. Individuals on insulin thera‐
py need to eat at consistent times synchronized with the time-actions of insulin, monitor
blood glucose levels, and adjust insulindoses for the amount o food usually eaten or re‐
quired ( Frany J. Marion et al., 1994).
2. Guidelines on energy balance, energy intake and food components
No nutrition recommendations can be made for the prevention of type 1 diabetes at this
time. (Franz MJ, et al., 2002), but increasing overweight and obesity in youth appears to be
related to the increased prevalence of type 2 diabetes, particularly in minority adolescents.
Although there are insufficient data at present to warrant any specific recommendations for
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the prevention of type 2 diabetes in youth, interventions similar to those shown to be effec‐
tive for prevention of type 2 diabetes in adults (lifestyle changes including reduced energy
intake and regular physical activity) are likely to be beneficial. Clinical trials of such inter‐
ventions are ongoing in children.
Individuals who have pre-diabetes or diabetes should receive individualized medical nutri‐
tion therapy (MNT); such therapy is best provided by a registered dietitian familiar with the
components of diabetes MNT. Meta-analysis of studies in non-diabetic, free-living subjects
and expert committees report that MNT reduces LDL cholesterol by 15–25 mg/dl. (Yu-Poth
S. et al., 1999. Grundy SM., et al. 1997 )
The prevalence of overweight children and adolescents with type I Diabetes mellitus has tri‐
pled over the past 20 years, which appears to correspond to the increasing prevalence of
obesity in the general population. The authors (Kliegman M Robert et al., 2007), have ob‐
served patients with type I diabetes, normal-weight preschool children have better glycemic
control than age-matched overweight children. This may mean that excess body weight sta‐
tus may impede achievement of therapeutic goals in this group of patients.
The basis for energy requirements calculations is the determination of ideal body-weight. It
is assessed corresponding to the respective tables comprising child’s age, gender and body
size data.
Guidelines for daily caloric requirements in children
• 1000 Kcal + 100 Kcal/year age ( for 0-12 year old)
• 1500-2000 kcal + 100 Kcal/year of age > 12 ( for females 12-15)
• 2000-2500 Kcal+ 200 Kcal/year of age > 12 ( for males 12-15)
Age kcal/kg/d Protein (in grams) kg/d
6 months 115 2.2
12 months 105 2.0
3 years 100 1.8
6 years 85 1.5
10 years 86 1.2
Male
11-14 years 60 1.0
15-18 years 42 0.85
19-22 years 41 0.80
Females
11-14 years 48 1.0
15-18 years 38 0.84
19-22 years 38 0.80
Adapted from National Academy of Sciences Food and Nutrition Board
Table 1.
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A recommendations and plans on intake of certain kinds of foods depends on daily energy
expenditure which is determined by the individual patient’s age, gender and level of physi‐
cal activity. (Lean, M.E. J et al. 1980) In reality, the practical assessment of energy intake re‐
lies on follow-up of the patients’ growth and body mass gain. If the tendency towards
obesity has been identified (which usually occurs in the puberty and after the growth spurt
cessation, most often in female patients) the energy intake should be reduced to 80-90% of
standard calculated intake. On the other hand, in children with insufficient body weight a
body mass deficit can be corrected using foods with high energy content. (Stepanović R., et
al. 1991)/ An adequate diet enables a pediatric patient to utilize ingested food effectively
even though the spontaneous endogenous insulin secretion ceased and life depends on ana‐
bolic effects of exogenous insulin administered usually in 2-3 daily doses. Since the insulin
doses are delivered in the regular diurnal manner, at the same time every day, the food in‐
take must be adjusted according to the dosage schedule, amount and type of administered
insulin. A meal should be placed 30-60 minutes after regular insulin dose (in fact, regular
insulin has an onset of action 15–60 min after injection, a peak effect 2–4 h after injection,
and a duration of action of ranging from 5 to 8 h) comparing to 15 min with the newer syn‐
thetic insulin analogues. Synthetic insulin analogues, both lispro and aspart have an onset of
action within 15 min, a peak in activity at 60–90 min, and a duration of action of 3–5 h.
Therefore, a total daily food intake should be divided into six meals. Breakfast/ lunch / sup‐
per ratio should comprise 20% / 30% / 20% of a total daily intake while two snacks and a
bedtime meal should consist of 10% of the daily intake each. Also, it is important to ingest
about the same amount of carbohydrates at the regullar time every day and to eat meals reg‐
ullarily in order to avoid the occurrence of hypoglycemic episodes. (Stepanović R., et al.
1991)
3. Carbohydrate
Dietary carbohydrate has both chemical structural features and form which have gained in
importance in recent years. The process of digestion of carbohydrate has been known for
many years and instinctively it is held that a monosaccharide must be absorbed more readi‐
ly than an oligosaccharide, which requires hydrolysis before absorption.
The recommended dietary allowance (RDA) for digestible carbohydrate is 130 g/day and is
based on providing adequate glucose as the required fuel for the central nervous system
without reliance on glucose production from ingested proteins and fats. Although brain fuel
needs can be met on lower-carbohydrate diets, long-term metabolic effects of very-low-car‐
bohydrate diets are unclear, and such diets eliminate many foods that are important sources
of energy, fiber, vitamins, and minerals and are important in dietary palatability (Institute of
Medicine:2002). There are no trials specifically in patients with diabetes restricting total car‐
bohydrate to <130 g/day. However, 1-year follow-up data from a weight-loss trialamong the
subset with diabetes indicated that the reduction in fasting glucose was 21 mg/dl (1.17
mmol/l) and 28 mg/dl (1.55 mmol/l) for the low-carbohydrate and low-fat diets, respectively,
with no significant difference in A1C levels (Stern L., et al. 2004).
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Department for Agriculture ( USDA) reveal that – 43%-47% of calories are contributed by
dietary carbohydrate, whereas 36-37% of calories are contributed by dietary fat, with 13%
from saturated fatty acids, 14% from monosaturated, and 7% from polyunsaturated. A re‐
duction in high dietary takes of saturated fats, trans-fatty acids and cholesterol (all of which
contains cholesterol-raising fatty acids) is an important goal to reduce the risk of cardiovas‐
cular disease. Although diabetes mellitus is usually categorized as a disease of carbohydrate
metabolism, abnormalities of lipoprotein metabolism and adipose tissue distribution are al‐
so common. Cardiovascular disease accounts for the majority of deaths in people with dia‐
betes. Analysis of the Multiple Risk Factor Intervention Trial data for men with diabetes
matched with non-diabetic men reported relative risk of death for men with diabetes was
increased at a range from 2.83 to 4.46 depending on their level of serum cholesterol. (Stamler
J. et al. 1993)
Approximately 70% of the carbohydrate content should be derived from complex such as
starch; intake of sucrose and highly refined sugars should be limited.
An intake of simple carbohydrates with high fiber foods - such as complex grains (bran),
vegetables (beans and peas containing galactomannan) and fruit (pectin) is recommended;
this combination of food slows intestinal food absorption, reduce postprandial hyperglyce‐
mia and lowers serum cholesterol levels (Stepanović R., et al. 1991).
4. Glycemic index and glycemic load
By definition, the glycemic index (GI), compares equal quantities of available carbohydrate
in foods and provides a measure of carbohydrate quality. Available carbohydrate can be cal‐
culated by summing the quantity of available sugars, starch, oligosaccharides, and malto‐
dextrins. By definition, (Salmeron J. etal 1997), the glycemic load (GL) is the product of a
food’s GI and its total available carbohydrate content: glycemic load = [GI × carbohydrate
(g)]/100.
Therefore, the GL provides a summary measure of the relative glycemic impact of a “typi‐
cal” serving of the food. Foods with a GL ≤10 have been classified as low glycemic load and
those with a value ≥20 as high glycemic load (Brand-Miller JC, Holt SHA, Petocz P: Reply to
R. Mendosa. Am J ClinNutr 77: 994–995, 2003). In healthy individuals, stepwise increases in
GL have been shown to predict stepwise elevations in postprandial blood glucose and/or in‐
sulin levels (Brand-Miller JC et al, 2003). It can be seen from the equation that either a low-
GI/high-carbohydrate food or a high-GI/low-carbohydrate food can have the same GL.
However, while the effects on postprandial glycemia may be similar, there is evidence that
the two approaches will have very different metabolic effects, including differences in β-cell
function, triglyceride concentrations, free fatty acid levels (Wolever TMS, et al. 2002), and ef‐
fects on satiety (Ball SD, et al. 2003).
Hence, the distinction has important implications for the prevention and management of
diabetes and cardiovascular disease. Our concern is that the use of the GL or “glycemic re‐
sponse” in isolation may lead to the habitual consumption of lower-carbohydrate diets.
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The use of the glycemic index has been shown to provide additional benefit to glycemic con‐
trol over that observed when total carbohydrate is considered alone (Brand-Miller. et al.
2003). This index compares glycaemic excursions after ingestion of a carbohydrate and com‐
pares it with the glycemic excursions after an equivalent amount of the monosaccharide glu‐
cose. Thus numerical values can be ascribed to potatoes, rice, bread, etc., which give a
comparative indication of glycemic consequence.
Factors that affect the glycemic response of foods are feeding rate, the rate of food ingestion,
food ingredients (fat, protein, fiber, starch) and methods of cooking and food processing. In‐
fluence on glycemic response and physiological mechanisms of degradation of consumed
food (pre-gastric and gastric hydrolysis, gastric emptying rate, intestinal hydrolysis and re‐
action to pancreatic and intestinal hormones). Bread, crackers, grain, potatoes, millet, corn,
and chips have a high GI (> 90). Bran, oatmeal, rice, buckwheat have medium glycemic in‐
dex (e.g. 70-90). Black bread, pasta, barley and cooked rice have the lowest glycemic in‐
dex(<70) (Dimitrijević- Srećković V. 2002).
A controlled study in children using the GI of foods found flexible dietary instruction based
on the food pyramid and low-GI choices achieved significantly better glycemic control after
12 months than more traditional dietary advice. (Gilbertson H. et al. 2001). In their study,
Miller JB et al confirmed the significant influence of the lower GI nutrition on postprandial
glucose levels. However, the impact on long-term glycemic control and co-morbidity was
less efficient than pharmacological treatment.
Choosing low-GI foods in place of conventional or high-GI foods has a small but clinically
useful effect on medium-term glycemic control in patients with diabetes. The incremental
benefit is similar to that offered by pharmacological agents that also target postprandial hy‐
perglycemia. (Jennie Brand-Miller et al. 2003)
In addition, several prospective observational studies have found that the overall GI and gly‐
cemic load (GI × g carbohydrate) of the diet, but not total carbohydrate content, are independ‐
ently related to the risk of developing type 2 diabetes (Salmeron J et al, 1997), cardiovascular
disease (Liu S et al, 2000), and some cancers (Augustin L, 2001, Franceschi S et al, 2001)
Low GI carbohydrate foods (GI < 55) may lower post-prandial hyperglycemia when they are
chosen to replace higher GI foods (GI > 70) (Brand-Miller J. et al. 2003) Examples of low GI
food sources include wholegrain breads, pasta, temperate fruits and dairy products. (Foster-
Powell K. et al. 2002) Glycemic load (GL) is another method of predicting the postprandial
blood glucose response, which takes into account both the GI of the food and the portion
size. (Colombani PC, 2004). There has been no assessment of its efficacy in children.
Artificial sweeteners are widely used among diabetic patients. Two kinds of sweeteners may
be distinguished:nutritive sweeteners which contain calories (fructose, sorbitol, mannitol) and
non-nutritive which are calories-free (saccharin, cyclamate, aspartame). Fructose has the ad‐
vantage over sucrose; for its better taste, slow absorption from the digestive system; no insulin
is required for itsutilization and it causes hyperglycemia less often The fructose intake should
be limited to 25g/d. Saccharin is about 500 times the sweeter than sucrose; its use may be con‐
nected to the increased risk of bladder carcinoma (Dimitrijevic-Srećković V., 2002).
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5. Fat
The proportion of fat content in total energy intake should be approximately 35% in young
children, and 25-30% in older children.
The vegetable fats have clearly advantage over animal ones. Intake decreases during child‐
hood from approximately 2 g/kg/day in early infancy to 1 g/kg/day for a ten year old and to
0.8–0.9 g/kg/day in late adolescence. (Kauffman FR, 2005). Substituting butter with margar‐
ine, vegetable oil for animal oil, and lean cuts of meat, poultry, and fish for fatty meats, such
as bacon, is advisable. These simple measures reduce serum low-density lipoprotein choles‐
terol, a predisposing factor to atherosclerotic disease.
Uncontrolled type I diabetes is associated with elevated plasma lipids, but adequate insulin
therapy usually restores lipid levels to normal. People with type I diabetes who are treated
with insulin generally have plasma cholesterol, VLDL cholesterol and triglyceride concen‐
trations similar to those of the general population of the same age and sex (Kern P, 1987).
Although not all studies agree, it appears that blood glucose control may directly influence
the levels of several plasma lipid components. Qualitative abnormalities such as changes in
a density of lipoprotein composition may exist even when the usual clinical measurements
of plasma lipids are normal (Dunn FL, 1992). Evidence that dietary fat and the development
of atherosclerosis are linked is controversial and there is little sign that a reduction in dietary
fat would reduce atherosclerotic disease. Epidemiological studies from Japan are often quot‐
ed and in other populations a fall in cardiovascular morbidity has coincided with alterations
in eating habits. (Nattras M., 1996) The dietary contents of polyunsaturated / saturated fatty
acids should optimally correspond to 1.2: 1.0 ratios.
The primary goal regarding management of dietary fat is to decrease the intake of total fat,
saturated fat, and trans-fatty acids (Franz MJ et al, 2002). Monounsaturated fatty acids (MU‐
FA) and polyunsaturated fatty acids (PUFA) can be used as substitutes to keep lipid intake
within recommended ranges or to improve the lipid profile.
Polyunsaturated fatty acids increase the production of lipid peroxides; some experimental
studies considered their influence on occurrence of certain malignancies. They are rich in
omega-6 fatty acids from sunflower oil and corn; moderate intake of these fatty acids lowers
LDL cholesterol, while high intake lowers HDL cholesterol. Omega-3 fatty acids are found
in deep sea blue fish (herring, mackerel, tuna and salmon). Their utilization from fish meat
is more effective than the utilization from pharmacological supplements. The recommended
intake of fish oil is 1.5-2.0 g / day. Omega-3 fatty acids moderately lower total cholesterol,
significantly reduce triglyceride levels and reduce platelet aggregation, blood pressure and
cardiovascular risk. However, they may increase hepatic glucose production, thus increas‐
ing blood glucose and hemoglobin A1-c levels. Therefore, in patients with impaired carbo‐
hydrate metabolism, the use of fish oil is not recommended; instead, blue sea fish meals
should be taken 2-3 times a week.
Monounsaturated fatty acids are found in olive oil, walnuts and sesame. Studies have
shown that application of these fatty acids for one month reduces insulin requirements and
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improve insulin sensitivity; decreases blood glucose and triglyceride levels and arterial
blood pressure as well. The Mediterranean diet, with increased use of olive oil-rich omega-9
fatty acids, reduces LDL cholesterol without affecting HDL cholesterol. Its intake improves
insulin sensitivity, blood glucose and triglyceride levels and blood pressure. These mecha‐
nisms explain the reduction in coronary heart disease in Mediterranean countries. Monoun‐
saturated fatty acids are more resistant to lipid peroxidation than the polyunsaturated fatty
acids and less involved in the pathogenesis of atherosclerosis.
Trans-isomers of polyunsaturated fatty acids formed during the hydrogenation process may
have potentially harmful effects. These trans-isomers are formed during solidification of
vegetable oils. They are found in margarine and pastries, and intake of these foods increases
LDL cholesterol and lowers HDL cholesterol. Therefore, in the UK and some European
countries the intake of these trans-isomers in the amounts more than 5 g / day is not recom‐
mended. A consideration was given on intake of long chain omega-3 fatty acids. Epidemio‐
logical research studies have shown that prolonged use of concentrated fish oil may have an
anti-atherogenic effect thanks to the high omega-3 acid contents (A. Simopoulos, 1991).
The existing nutritional recommendations of the European Association for the Study of Dia‐
betes (EASD) and American Diabetes Association (ADA) on dietary composition promote
greater flexibility in the proportions of energy derived from carbohydrate and from mono‐
unsaturated fat (MUFA). MUFA are promoted as the main source of dietary fat because of
their lower susceptibility of lipid peroxidation and consequent lower atherogenic potential
( Kratz M., et al. 2002).
In diabetes, cholesterol intake is limited to a maximum of 300 mg daily, in order to slow
down the development of atherosclerotic process. This means that cholesterol-rich foods
(brain, egg yolk) should be avoided, and lean meat (veal, beef, chicken) or fish should be
used instead; instead of whole milk a milk containing 2.8% fat.
6. Proteins
Proteins are an essential nutrient, necessary for normal growth and development in child‐
hood. Adequate protein ingestion is critical in normal muscle development. Proteins are an
essential source of nitrogen.
The recommended intake is 15% of total caloric daily intake in older children and 20% in
younger. The intake of proteins per kilogram of body weight should be higher in infants,
children and adolescents in comparison to adults in order to support growth and develop‐
ment. The daily requirements are about 1.5g/kg for preschool children for and somewhat
less -1g/kg for the children in school age –e.g., until the period of rapid growth during pub‐
erty, when the requirements increase again. (Stepanović R. et al 1991)
In diabetes variation in dietary protein may influence metabolic control by altering gluco‐
neogenic substrate availability as well as insulin and contra-regulatory hormone secretion
(Nuttall FQ., 1983).
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Only in poorly controlled diabetes or in a period of recovering from ketoacidosis, the
amount of protein should be greater than 2g/kg. The most important sources of protein are
meat, fish and egg whites, but proteins are also represented in foods rich in carbohydrates
(legumes, bread and cereals)
Excessive protein intake has also been implicated in the pathogenesis of diabetic renal disease
and restricting its intake may retard the progression of nephropathy (Brenner BM., et al 1982)
The caloric mixture should comprise approximately 55% carbohydrate, 30% fat and 15%
protein. A daily intake should be divided in 6-7 meals; breakfast and lunch should be repre‐
sented with 20% of total caloric needs, dinner with 30% and each snack should contain 10%
of daily calorie inputs. Each meal should be taken at certain time during the day with no
major or frequent deviations. A bed time snack is considered an essential part of the regi‐
men. This is necessary to prevent nocturnal hypoglycemia. The bed time snack includesat
least 7-8g of protein, the amount equivalent to that in a meat or a milk exchange (7 to 8g).
(Rudolph AM et al 1996)
7. Fiber
Dietary fibers may be divided into soluble (found in fruits, oats, barley, legumes and root
vegetables) and insoluble (found in wheat, wheat bran, grains and some vegetables). Soluble
fibers are mainly hemi-cellulose compounds that bind water, bile acids and build seques‐
tered forms with monosaccharides and disaccharides; thus, they partially inhibit the action
of digestive enzymes and slow down the process of absorption of food by increasing the
time of intestinal passage. This action lowers postprandial glycemia and total cholesterol
levels. These fibers also reduce the levels of lipids, cholesterol, LDL cholesterol and body
mass. Soluble fiber supplements such as pectin, fiber from carob can improve metabolic reg‐
ulation. Insoluble dietary fibers have little effect on blood glucose and no effects on lipids,
but may increase satiety and inhibit hunger, and thus induce positive effects in obese pa‐
tients with diabetes (Dimitrijevic-Srećković V., 2002).
8. Micronutrients: Vitamins and minerals
By complying with a proper and balanced diet, people with diabetes daily take adequate
amount of vitamins and minerals, so there is usually no need for pharmacological supple‐
ments. The exceptions are some trace elements-copper, selenium and magnesium.
Individuals on weight –reducing diet, strict vegetarians patients with poor metabolic control
and patients in critical care environments require special attention and assessment. A sup‐
plementation therapy containing vitamins and minerals is most often needed in these cases.
In animal models it was shown that chromium deficiency was often associated with elevat‐
ed blood glucose, cholesterol and triglyceride levels (Schrroeder HA, 1966;Wolscroft J et al,
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1977). While serum zinc levels are generally lower in people with diabetes, zinc replacement
is only suggested to be of benefit in helping to heal venous leg ulcer (Hoolbook T., et al
1979). There may be a need for magnesium replacement in patients with poor glycemic con‐
trol or who are on diuretics. Magnesium depletion has been associated with decreased insu‐
lin sensitivity, which may improve with oral supplementation (Beaugerie L et al, 1990).
Some studies indicated that magnesium is a novel factor implicated to the pathogenesis of
the diabetic complications. Magnesium plays a fundamental role as a cofactor in various en‐
zymatic reactions of energy metabolism. Magnesium is a cofactor in cell membrane glucose
– transporting mechanisms, as well as in various enzymes in carbohydrate oxidation. It is
also involved, at multiple levels, in insulin secretion, binding and activity. Magnesium defi‐
cit has been described in patients with type I diabetes. Hypomagnesemia can also be the
cause or a result of diabetes complications. If it is followed by diabetes, osmotic dieresis may
play a role in the mechanisms responsible for magnesium deficiency. Magnesium loss may
be linked to the development of diabetes complications via a reduction in the rate of inositol
transport and its subsequent intracellular depletion that might enhance the development of
complications. Magnesium is also taking part as a cofactor in many enzymes which are in‐
volved in lipid metabolism. Magnesium administration could decrease triglyceride, choles‐
terol and LDL cholesterol levels and also increase HDL cholesterol (Soltani N., 2011).
9. Sodium
The American Heart Association recommends that sodium intake should not exceed 3000
mg/day, while other authors (National High Blood Pressure Education Program, 1993) rec‐
ommend not more than 2400mg/day. Individuals with mild to moderate hypertension
should ingest no more than 2400mg of sodium daily (or less than 6 g/day of sodium chlor‐
ide). A study performed in mildly hypertensive subjects with diabetes on moderate dietary
sodium restriction showed a reduction of approximately 20 mmHg in systolic blood pres‐
sure. A difference in diastolic blood pressure was not achieved (Dodson PM., et al 1989).
Routine supplementation with antioxidants, such as vitamins E and C and carotene, is not
advised because of lack of evidence of efficacy and concern related to long-term safety.
10. Recommended foods
A dietary intake of dark bread, rye, whole-meal bread, oats and barley flakes, porridge of
maize flour, rice, spaghetti, potatoes, beans and lentils as a substitute for bread is recom‐
mended. Also, use of all kinds of vegetables (legumes, root and leafy vegetables) in the
amount of 400-500 g/d (250g boiled, 250g fresh). All kinds of fruits are allowed, except for
grapes, figs, prunes. The amount of fruit should be 500 g per day, divided into several in‐
stallments. In addition, fresh fruit has an advantage over the pressed juice, since it is rich in
dietary fibers.
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Component Comment
Protein Not"/> 1g per body weight
Total fat
Saturated+trans-unsaturated fat
n-6 Polyunsaturated fat
n-3 Polyunsaturated fat
cis-Monounsatureted fat
< 35% of energy intake
<10% of energy intake
<10% of energy intake
Eat fish, especially oily fish, once or twice weekly. Fish oil
supplements-not recommended
10-20% ( 60-70%) energy intake
Total carbohydrate
Sucrose
45-60%
Up to 10% of daily energy requirements, provided it is
eaten within the healthy diet. Those who are overweight
or who have hypertriglyceridemia should consider using
not-nutritive sweeteners where appropriate
Fiber No quantitative recommendation
Soluble fiber"/> has beneficial effect on glycaemic and
lipid metabolism
Insoluble fiber"/> no direct effect on glycaemic and lipid
metabolism but its high satiety content may benefit those
trying to lose weight and its advantageous to
gastrointestinal health
Vitamins and anti-oxidants Encourage foods naturally rich in vitamins and anti-
oxidants. With exception of some patients e.g.
malnourishment, cancer etc. there is no evidence for the
use supplements and some evidence that some are
harmful
Salt Approx 6 g sodium chloride per day
Table 2. (Connor H. et al. 2003)
The diet may contain dairy products - a skim milk, buttermilk, yogurt with 3.2% milk fat,
cream, sour cream, butter, fatty cheeses and cheese. Lean meat (chicken, turkey, veal, beef,
lamb, horse, deer, fish-river and sea), and cured meats from chicken, horse sausages, and
sardines drained of oil are also recommended. Pork, duck, goose, sheep meat, fatty fish (cat‐
fish, perch, carp) should be avoided. The recommended intake is two poached eggs a week
(in people with high cholesterol and triglyceride levels intake of yolk is not allowed). The
use of vegetable fats is preferable (olive and sunflower oil) (Srećković V. Dimitrijevic, 2002).
The intake of starch should be provided by eating bread, grains, cereal, pasta, and starchy
vegetables like corn and potatoes. They provide carbohydrate, vitamins, minerals, and fiber.
Whole grain starches are healthier because they have more vitamins, minerals, and fiber.
The UK DAFNE Project (Dose Adjustment For Normal Eating) includes adults with type 1
diabetes participating in a group program. It is a kind of a group skills-based training with
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the aim to provide knowledge of flexible insulin meal–by-meal adjustments in order to
match the carbohydrate content in a free diet.The groups consist of adult participants with
type 1 diabetes of>2 years duration, without advanced complication, with HBA1c levels of
7.5-12%. DAFNE involves attending a 5-day training course plus a follow-up session around
8 weeks after the course and yearly half-day top-up sessions. The structured teaching pro‐
gram is delivered to groups of 6-8 participants and covers topics including carbohydrate es‐
timation, blood glucose monitoring, insulin regimens, hypoglycemia, illness and exercise. A
significant reductions in HbA1-c were found after 6 ( -1.0%) and 12 months ( -0.5%) of inter‐
vention, respectively. Also, a significant improvement in quality of life and well-being and
satisfaction with treatment scores was registered (Nutrition Sub-Committee of the Diabetes
Care Advisory Committee of Diabetes UK, 2003).
Exchange Calories Grams of
Carbohydrate
Grams of Protein Grams of Fat
Bread/starch 80 15 3 Trace
Fruit 60 15 - -
Meat
Lean 55 7 3 -
Medium fat 75 - 7 3
High fat 100 - 7 8
Milk
Skim 90 12 8 Trace
Low fat 120 12 8 5
Whole 150 12 8 8
Fat 45 - - 5
Vegetable 25 5 2 -
Table 3. Nutrient composition of the exchanges
11. Nutrition recommendations for controlling diabetes complications
If there was a family history of hypercholesterolemia (total cholesterol >240 mg/dl) or a fam‐
ily cardiovascular event before age of 55 years, or if family history was unknown, a fasting
lipid profile should be performed on children >2 years of age soon after diagnosis (after glu‐
cose control has been established). If family history is not of concern, then the first lipid
screening should be considered at puberty (≥10 years). All children diagnosed with diabetes
at or after puberty should have a fasting lipid profile performed soon after diagnosis (after
glucose control has been established
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Initial therapy should consist of optimization of glucose control and MNT using a Step 2
AHA diet (American Heart Association, 2010 Dietary Guidelines) aimed at a decrease in the
amount of saturated fat in the diet. People diagnosed with type 1 diabetes in childhood have
a high risk of early subclinical (Krantz JS et al, 2004, Järvisalo MJ et al, 2004, Haller MJ.,
2004), and clinical (Orchard TJ., et al. 2001) CVD. Although intervention data are lacking, the
AHA categorizes children with type 1 diabetes in the highest cardiovascular risk group and
recommends both lifestyle and pharmacologic treatment for those with elevated LDL cho‐
lesterol levels (Kavey RE et al, 2006; McCrindle BW et al, 2007). Initial therapy should be
with a Step 2 AHA diet, which restricts saturated fat to 7% of total calories and restricts diet‐
ary cholesterol to 200 mg/day. Data from randomized clinical trials in children as young as 7
months of age indicate that this diet is safe and does not interfere with normal growth and
development
A proper nutrition and physical activity is essential for the prevention of arterial hyperten‐
sion in diabetic patients. Hypertension, which is predictive of progression of micro- as well
as macrovascular complications of diabetes, can be prevented and managed with interven‐
tions including weight loss, physical activity, moderation of alcohol intake, and diets such as
DASH (Dietary Approaches to Stop Hypertension). The DASH diet emphasized fruits, vege‐
tables, and low-fat dairy products; included whole grains, poultry, fish, and nuts; and was
reduced in fats, red meat, sweets, and sugar-containing beverages Treatment of high-normal
blood pressure (systolic or diastolic blood pressure consistently above the 90th percentile for
age, sex, and height) should include dietary intervention and exercise aimed at weight con‐
trol and increased physical activity, if appropriate(Chobanian AV., et al. 2003,Sacks FM., et
al. 2001, Appel LJ., et al. 2006).
If target blood pressure is not reached with 3–6 months of lifestyle intervention, pharmaco‐
logic treatment should be considered (Standards of Medical Care in Diabetes—2012)
In individuals with diabetes and macroalbuminuria, reducing protein from all sources to 0.8
g/kg body wt/ day has been associated with slowing the decline in renal function (Franz MJ.,
et al 2002, Hansen H., et al 2002 ) ; however, such reductions in protein need to maintain
good nutritional status in patients with chronic renal failure (Meloni C., et al 2002)
Although several studies have explored the potential benefit of plant proteins in place of an‐
imal proteins and specific animal proteins in diabetic individuals with microalbuninuria, the
data are inconclusive. (Wheeler ML., et al 2002)
Medical nutrition therapy is important in preventing diabetes, managing existing diabetes,
and preventing, or at least slowing, the rate of development of diabetes complications (Nu‐
trition Recommendations and Interventions for Diabetes, 2008).
12. Nutritional management of exercise and sport
A regular physical activity improves glucose tolerance, increases muscle mass, reduces body
fat mass and increases the number of insulin receptors and glucose entry into cells. A blood
flow to the muscle and expansion of capillary space are stimulated during physical activity,
which allows a better flow of insulin to muscle cells. (Zergollern Lj., et al., 1994) Regular
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physical exercise improves insulin resistance and reduction of triglyceride levels and in‐
creases total HDL and HDL2 concentration; it also helps in lowering blood pressure. It re‐
duces mortality in type I diabetes and may reduce HbA1c up to 0.7% in type II diabetes (Ha
TKK. et al., 1998).
The U.S. Department of Health and Human Services' Physical Activity Guidelines for Amer‐
icans (U.S. Department of Health and Human Services, 2008), suggest that adults over age
18 years have up to 150 min/week of moderate-intensity, or 75 min/week of vigorous aerobic
physical activity, or an equivalent combination of the two. In addition, the guidelines sug‐
gest that adults also do muscle-strengthening activities that involve all major muscle groups
two or more days per week. Studies included in the meta-analysis of effects of exercise inter‐
ventions on glycemic control (Boulé NG. et al., 2001). The DPP lifestyle intervention, which
included 150 min/week of moderate intensity exercise, had a beneficial effect on glycemia in
those with prediabetes. Therefore, it seems reasonable to recommend that people with dia‐
betes try to follow the physical activity guidelines for the general population.
In patients who are in poor metabolic control, vigorous exercise may precipitate ketoacido‐
sis because of the exercise-induced increase in the counter-regulatory hormones. On the oth‐
er hand, there is an excessive amount of insulin in the body, the hepatic glucose production
in response to excess muscle consumption could be insufficient, and symptoms of hypogly‐
cemia might ensue.
When people with type 1 diabetes are deprived of insulin for 12–48 h and becomeketotic,
exercise can worsen hyperglycemia and ketosis (Berger M, Berchtold P., et al., 1977); there‐
fore, vigorous activity should be avoided in the presence of ketosis. However, it is not neces‐
sary to postpone exercise based simply on hyperglycemia, provided the patient feels well
and urine and/or blood ketones are negative.
In individuals taking insulin and/or insulin secretagogues, physical activity can cause hypo‐
glycemia if medication dose or carbohydrate consumption is not altered. For individuals on
these therapies, additional carbohydrate should be ingested if pre-exercise glucose levels are
<100 mg/dl (5.6mmol/l). Hypoglycemia is rare in diabetic individuals not treated with insu‐
lin or insulin secretagogues, and no preventive measures for hypoglycemia are usually ad‐
vised in these cases.
It is therefore desirable that every person with diabetes planning or having physical exercise
carry a glucose or sacharose preparation in form of tablets, jelly or candy or sugar in the
form of cubes, candy, juice or soda. If hypoglycemias occur frequently, the entire dose insu‐
lin should be reduced by 10-15%.
The enhanced energy expenditure resulting from exercise increases the need for additional
protein which should be met by increased consumption of nutritionally balanced diet. A
small amount of additional protein may be required for muscle growth resulting from
chronic physical conditioning.
Physical activity can acutely increase urinary protein excretion. However, there is no evi‐
dence that vigorous exercise increases the rate of progression of diabetic kidney disease, and
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there is likely no need for any specific exercise restrictions for people with diabetic kidney
disease (Mogensen CE., 2002).
13. Conclusion
In conclusion, dietary recommendations for diabetic patients should be based on healthy
eating recommendations suitable for all children and adults. Generally, the ideal diet for the
normalization of glycemic control in people with diabetes has not yet been designed. In fact,
there may be as many diets for diabetes as people with diabetes, and they could be based on
the many individual manifestations, presentations, and complications of the disease. Indi‐
viduals on insulin therapy need to eat at consistent times synchronized with the time-ac‐
tions of insulin, monitor blood glucose levels, and adjust insulin doses for the amount of
food usually eaten.
Medical nutrition therapy is important in preventing diabetes, managing existing diabetes,
and preventing, or at least slowing, the rate of development of diabetes complications. No
nutrition recommendations can be made for the prevention of type 1diabetes at this time.
Although there are insufficient data at present to warrant any specific recommendations for
the prevention of type 2 diabetes in youth, interventions similar to those shown to be effec‐
tive for prevention of type 2 diabetes in adults are likely to be beneficial.
The caloric mixture should comprise approximately 55% carbohydrate, 30% fat and 15%
protein. A flexible dietary instruction based on the food pyramid and low-glycemic index
choices achieved significantly better glycemic control than more traditional dietary advice.
Several prospective observational studies have shown that the overall glycemic index and
glycemic load of the diet, but not total carbohydrate content, are independently related to
the risk of developing type 2 diabetes. An intake of simple carbohydrates with high fiber
foods - such as complex grains, vegetables and fruit slows the intestinal absorption. It also
reduces postprandial hyperglycemia and lowers serum cholesterol levels.
The primary goal regarding dietary fat is to decrease the intake of total fat, saturated fat, and
trans-fatty acids. Monounsaturated fat should be promoted as the main source of dietary fat
because of their lower susceptibility to lipid peroxidation and consequent lower atherogenic
potential. Moderate intake of omega 3 and omega-9 fatty acids lowers LDL cholesterol.
If there was a family history of hypercholesterolemia or a family cardiovascular event before
age of 55 years, or if family history was unknown, a fasting lipid profile should be per‐
formed on children >2 years of age soon after diagnosis (after glucose control has been es‐
tablished). All children diagnosed with diabetes at or after puberty should have a fasting
lipid profile performed soon after diagnosis (after glucose control has been established.
AHA categorizes children with type 1 diabetes in the highest for cardiovascular risk and
recommends both lifestyle and pharmacologic treatment for those with elevated LDL cho‐
lesterol levels.
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Proteins are an essential nutrient, necessary for normal growth and development in child‐
hood. The recommended intake is 15% of total caloric daily intake in older children and 20%
in younger children. The daily requirements are about 1.5g/kg for preschool children for
and somewhat less -1g/kg for the children in school age –e.g., until the period of rapid
growth during puberty, when the requirements increase again. Only in poorly controlled
diabetes or in a period of recovering from ketoacidosis, the amount of protein should be
greater than 2g/kg. Variable dietary proteins may influence metabolic control by altering
gluconeogenic substrate availability as well as insulin and contra-regulatory hormone secre‐
tion. Excessive protein intake has also been implicated in the pathogenesis of diabetic renal
disease. In individuals with diabetes and macroalbuminuria, reducing protein from all sour‐
ces to 0.8 g • kg body wt−1 • day−1 has been associated with slowing the decline in renal
function.
Hypertension can be prevented and managed with interventions including weight loss,
physical activity, moderation of alcohol intake, and diets such as DASH (Dietary Ap‐
proaches to Stop Hypertension. 2006). If target blood pressure is not reached with 3–6
months of lifestyle intervention, pharmacologic treatment should be considered. Insoluble
dietary fibers have little effect on blood glucose and no effects on lipids, but they may in‐
crease satiety and inhibit hunger, thus inducing positive effects in obese diabetic patients.
By complying with a proper and balanced diet, people with diabetes take adequate amount
of vitamins and minerals, so there is usually no need for pharmacological supplements. Zinc
replacement is only suggested to be of benefit in helping to heal venous leg ulcer.
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